Cencora Announces Q2 2026 Earnings Release Date

Pharmaceutical company Cencora will report quarterly results on May 6, 2026.

Apr. 2, 2026 at 12:59am

Got story updates? Submit your updates here. ›

Cencora, Inc., a publicly traded pharmaceutical company, announced that it will release its financial results for the second quarter of fiscal year 2026 on Wednesday, May 6, 2026, prior to the opening of trading on the New York Stock Exchange.

Why it matters

As a major pharmaceutical company, Cencora's quarterly earnings are closely watched by investors and analysts to gauge the overall health and performance of the business. The timing of this earnings release will provide the market with an update on Cencora's operations and financial standing halfway through the fiscal year.

The details

Cencora, which trades on the NYSE under the ticker symbol COR, will report its Q2 2026 results before the market opens on May 6, 2026. The company did not provide any additional details about what will be included in the earnings release or if there will be a related conference call with management.

  • Cencora will release Q2 2026 results on May 6, 2026.

The players

Cencora, Inc.

A publicly traded pharmaceutical company that trades on the New York Stock Exchange under the ticker symbol COR.

Got photos? Submit your photos here. ›

The takeaway

Cencora's upcoming earnings release will provide investors with an important mid-year update on the company's financial performance and business operations as it navigates the competitive pharmaceutical industry.